Request Sample Inquiry
Multiple Sclerosis Drugs Market

Multiple Sclerosis Drugs Market

Multiple Sclerosis Drugs Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

147

Base Year:

2022

Date

Oct - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1859

Segments Covered
  • By Drug Class By Drug Class Immunosuppressants, Immunomodulators, Interferons, Other Drug Classes
  • By Route of Administration By Route of Administration Oral, Injectable
  • By Distribution Channel By Distribution Channel Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 25.90 Billion
Revenue 2030Revenue 2030: USD 34.36 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 3.60%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Multiple Sclerosis Drugs Market Segment Analysis

  • Multiple Sclerosis Drugs Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
    • Immunosuppressants
    • Immunomodulators
    • Interferons
    • Other Drug Classes
  • Multiple Sclerosis Drugs Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
    • Oral
    • Injectable
  • Multiple Sclerosis Drugs Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
    • North America
      • North America Multiple Sclerosis Drugs Market, by Drug Class
        • Immunosuppressants
        • Immunomodulators
        • Interferons
        • Other Drug Classes
      • North America Multiple Sclerosis Drugs Market, by Route of Administration
        • Oral
        • Injectable
      • North America Multiple Sclerosis Drugs Market, by Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • U.S.
        • U.S. Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • U.S. Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • U.S. Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Canada
        • Canada Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • Canada Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Canada Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Mexico
        • Mexico Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • Mexico Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Mexico Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
    • Europe
      • Europe Multiple Sclerosis Drugs Market, by Drug Class
        • Immunosuppressants
        • Immunomodulators
        • Interferons
        • Other Drug Classes
      • Europe Multiple Sclerosis Drugs Market, by Route of Administration
        • Oral
        • Injectable
      • Europe Multiple Sclerosis Drugs Market, by Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • U. K.
        • U.K. Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • U.K. Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • U.K. Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • France
        • France Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • France Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • France Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Germany
        • Germany Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • Germany Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Germany Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Italy
        • Italy Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • Italy Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Italy Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Spain
        • Spain Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • Spain Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Spain Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Rest of Europe
        • Rest of Europe Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • Rest of Europe Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Rest of Europe Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
    • Asia Pacific
      • Asia Pacific Multiple Sclerosis Drugs Market, by Drug Class
        • Immunosuppressants
        • Immunomodulators
        • Interferons
        • Other Drug Classes
      • Asia Pacific Multiple Sclerosis Drugs Market, by Route of Administration
        • Oral
        • Injectable
      • Asia Pacific Multiple Sclerosis Drugs Market, by Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • China
        • China Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • China Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • China Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Japan
        • Japan Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • Japan Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Japan Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Germany
        • Germany Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • Germany Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Germany Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • India
        • India Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • India Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • India Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • South Korea
        • South Korea Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • South Korea Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • South Korea Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • South East Asia
        • South East Asia Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • South East Asia Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • South East Asia Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Rest of Asia Pacific
        • Rest of Asia Pacific Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • Rest of Asia Pacific Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Rest of Asia Pacific Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
    • Latin America
      • Latin America Multiple Sclerosis Drugs Market, by Drug Class
        • Immunosuppressants
        • Immunomodulators
        • Interferons
        • Other Drug Classes
      • Latin America Multiple Sclerosis Drugs Market, by Route of Administration
        • Oral
        • Injectable
      • Latin America Multiple Sclerosis Drugs Market, by Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • Brazil
        • Brazil Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • Brazil Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Brazil Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Argentina
        • Argentina Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • Argentina Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Argentina Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Rest of Latin America
        • Rest of Latin America Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • Rest of Latin America Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Rest of Latin America Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
    • Middle East & Africa
      • Middle East & Africa Multiple Sclerosis Drugs Market, by Drug Class
        • Immunosuppressants
        • Immunomodulators
        • Interferons
        • Other Drug Classes
      • Middle East & Africa Multiple Sclerosis Drugs Market, by Route of Administration
        • Oral
        • Injectable
      • Middle East & Africa Multiple Sclerosis Drugs Market, by Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • GCC Countries
        • GCC Countries Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • GCC Countries Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • GCC Countries Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • South Africa
        • South Africa Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • South Africa Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • South Africa Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
      • Rest of Middle East & Africa
        • Rest of Middle East & Africa Multiple Sclerosis Drugs Market, by Drug Class
          • Immunosuppressants
          • Immunomodulators
          • Interferons
          • Other Drug Classes
        • Rest of Middle East & Africa Multiple Sclerosis Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Rest of Middle East & Africa Multiple Sclerosis Drugs Market, by Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Online Pharmacy
FAQ
Frequently Asked Question
  • The global Multiple Sclerosis Drugs valued at USD 25.90 Billion in 2022 and is expected to reach USD 34.36 Billion in 2030 growing at a CAGR of 3.60%.

  • The prominent players in the market are Celgene Corporation, Acorda Therapeutics Inc., Biogen Inc., Actelion Pharmaceuticals (Johnson & Johnson), EMD Serono (Merck KGaA), Bayer AG, Teva Pharmaceutical Industries Ltd., Novartis AG., Sanofi, F. Hoffmann-La Roche Ltd..

  • The market is project to grow at a CAGR of 3.60% between 2023 and 2030.

  • The driving factors of the Multiple Sclerosis Drugs include

    • Significant R&D Investment by Market Players to Boost the Market

  • North America was the leading regional segment of the Multiple Sclerosis Drugs in 2022.